Human interferon-inducible protein 10,IP-10 ELISA Kit CSB-E08181h-IS CUSABIO
$50.00
In stock
SKU
CSB-E08181h-IS
Product Details
| Uniprot No. | P02778 |
| Species | Homo sapiens (Human) |
| Storage | Store at 2-8°C. Please refer to protocol. |
| Sensitivity | 3.9 pg/mL |
| Troubleshooting and FAQs | ELISA kit FAQs |
| Lead Time | 3-5 working days after you place the order, and it takes another 3-5 days for delivery via DHL or FedEx. |
| Associated names | Interferon gamma induced factor MOB1; mouse; homolog of ELISA Kit; Interferon gamma induced protein 10 ELISA Kit; 10 kDa interferon gamma induced protein ELISA Kit; 10 kDa interferon gamma-induced protein ELISA Kit; C X C motif chemokine 10 ELISA Kit; C7 ELISA Kit; Chemokine (C X C motif) ligand 10 ELISA Kit; Chemokine CXC motif ligand 10 ELISA Kit; Crg 2 ELISA Kit; CRG2 ELISA Kit; CXCL10 ELISA Kit; CXCL10(1-73) ELISA Kit; CXL10_HUMAN ELISA Kit; Gamma IP10 ELISA Kit; Gamma-IP10 ELISA Kit; gIP 10 ELISA Kit; GIP10 ELISA Kit; IFI10 ELISA Kit; INP 10 ELISA Kit; INP10 ELISA Kit; Interferon activated gene 10 ELISA Kit; Interferon activated gene 10 ELISA Kit; Interferon gamma induced cell line ELISA Kit; Interferon inducible cytokine IP 10 ELISA Kit; Interferon inducible cytokine IP10 ELISA Kit; IP 10 ELISA Kit; IP-10 ELISA Kit; Mob 1 ELISA Kit; MOB1 ELISA Kit; Protein 10 from interferon (gamma) induced cell line ELISA Kit; SCYB10 ELISA Kit; Small inducible cytokine B10 ELISA Kit; Small inducible cytokine B10 precursor ELISA Kit; Small inducible cytokine subfamily B (Cys X Cys) member 10 ELISA Kit; Small inducible cytokine subfamily B CXC member 10 ELISA Kit; Small inducible cytokine subfamily B; member 10 ELISA Kit; Small-inducible cytokine B10 ELISA Kit |
| Abbreviation | CXCL10 |
| Sample Types | serum, plasma, tissue homogenates |
| Detection Range | 15.6 pg/mL-1000 pg/mL |
| Assay Time | 1-5h |
| Sample Loading Volume | 50-100ul |
| Detection Wavelength | 450 nm |
| Research Area | Immunology |
| Assay Principle | quantitative |
| Measurement | Sandwich |
| Precision | headers: Intra-assay Precision (Precision within an assay): CV%<8%; rows: Intra-assay Precision (Precision within an assay): CV%<8%: Intra-assay Precision (Precision within an assay): CV%<8%; 1: Three samples of known concentration were tested twenty times on one plate to assess.; Intra-assay Precision (Precision within an assay): CV%<8%: Inter-assay Precision (Precision between assays): CV%<10%; 1: Three samples of known concentration were tested in twenty assays to assess. |
| Linearity | headers: To assess the linearity of the assay, samples were spiked with high concentrations of human IP-10 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.; rows: To assess the linearity of the assay, samples were spiked with high concentrations of human IP-10 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.: To assess the linearity of the assay, samples were spiked with high concentrations of human IP-10 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.; 2: Sample; 3: Serum(n=4); 1: 1:1; 2: Average %; 3: 98; 1: Range %; 2: 94-103; 1: 1:2; 2: Average %; 3: 89; 1: Range %; 2: 85-95; 1: 1:4; 2: Average %; 3: 101; 1: Range %; 2: 96-107; 1: 1:8; 2: Average %; 3: 97; 1: Range %; 2: 92-103 |
| Recovery | headers: The recovery of human IP-10 spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.; rows: The recovery of human IP-10 spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.: The recovery of human IP-10 spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.; 1: Sample Type; 2: Average % Recovery; 3: Range; 1: Serum (n=5); 2: 92; 3: 86-98; 1: EDTA plasma (n=4); 2: 97; 3: 90-100 |
| Typical Data | headers: These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.; rows: These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.: These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.; ; ; 1: pg/ml; 2: OD1; 3: OD2; 4: Average; 5: Corrected; 1: 1000; 2: 2.998; 3: 3.134; 4: 3.066; 5: 2.942; 1: 500; 2: 1.662; 3: 1.667; 4: 1.664; 5: 1.541; 1: 250; 2: 1.010; 3: 0.978; 4: 0.994; 5: 0.870; 1: 125; 2: 0.520; 3: 0.529; 4: 0.525; 5: 0.401; 1: 62.5; 2: 0.362; 3: 0.341; 4: 0.352; 5: 0.228; 1: 31.2; 2: 0.219; 3: 0.229; 4: 0.224; 5: 0.100; 1: 15.6; 2: 0.180; 3: 0.184; 4: 0.182; 5: 0.058; 1: 0; 2: 0.122; 3: 0.125; 4: 0.124 |
| ELISA Data Analysis | ELISA Standard Curve & Curve Expert software |
| Shelf Life | 6 months |
| Description | This ELISA kit provides quantitative measurement of CXCL10 (IP-10) in human samples, supporting research into interferon-γ-driven immune signaling and chemokine-mediated T cell recruitment. Because CXCL10 levels can shift dramatically between homeostatic and inflammatory states, the kit is designed to capture this dynamic range without requiring extensive sample manipulation. Detection Range: The 15.6–1000 pg/mL range spans baseline circulating CXCL10 concentrations in healthy serum (~50–300 pg/mL) through the elevated levels seen in active viral infection, autoimmunity, or transplant rejection, often exceeding 500 pg/mL. Most serum and plasma samples can be assayed neat or with minimal dilution, while inflamed tissue homogenates may require titration. Sensitivity: At 3.9 pg/mL, the kit detects CXCL10 in low-expression contexts such as early post-infection timepoints, immunosuppressed patient plasma, or unstimulated cell culture supernatants where concentrations fall well below normal circulating levels. Sample Compatibility: Validation across serum, plasma, and tissue homogenates enables paired systemic-versus-local analyses — for example, correlating circulating CXCL10 with intratumoral or graft-site chemokine gradients within a single study. Assay Efficiency: The 1–5 hour protocol and 50–100 µL sample volume accommodate longitudinal clinical cohort studies and small-volume pediatric or biopsy-derived specimens where repeated sampling is necessary. This kit is well suited for studies of viral hepatitis immune monitoring, solid organ transplant rejection, and tumor immune microenvironment profiling. |
Reviews
Write Your Own Review